Filing Details

Accession Number:
0001104659-22-049156
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-22 20:31:04
Reporting Period:
2022-01-01
Accepted Time:
2022-04-22 20:31:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651407 Checkpoint Therapeutics Inc. CKPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1434718 Iii F James Oliviero 95 Sawyer Rd, Suite 110
Waltham MA 02453
Ceo, President And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-01 302,777 $3.11 3,305,433 No 4 F Direct
Common Stock Disposition 2022-01-06 53,024 $2.77 3,252,409 No 4 F Direct
Common Stock Disposition 2022-01-24 143,136 $2.19 3,109,273 No 4 F Direct
Common Stock Disposition 2022-01-30 31,972 $2.46 3,077,301 No 4 F Direct
Common Stock Disposition 2022-02-24 117,657 $1.85 2,959,644 No 4 F Direct
Common Stock Disposition 2022-04-04 86,353 $1.79 2,873,291 No 4 S Direct
Common Stock Disposition 2022-04-05 14,030 $1.77 2,859,261 No 4 S Direct
Common Stock Disposition 2022-04-13 21,258 $1.51 2,838,003 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer.
  2. Includes shares of restricted Common Stock, which vest over various time periods.
  3. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.77 to $1.81. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.75 to $1.78. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  5. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.51 to $1.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.